Canada Life’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-171
Closed -$9K 2472
2022
Q1
$9K Buy
171
+48
+39% +$2.98K ﹤0.01% 2446
2021
Q4
$8K Buy
123
+47
+62% +$4.56K ﹤0.01% 2459
2021
Q3
$11K Hold
76
﹤0.01% 2504
2021
Q2
$10K Hold
76
﹤0.01% 2539
2021
Q1
$13K Hold
76
﹤0.01% 2551
2020
Q4
$15K Hold
76
﹤0.01% 2575
2020
Q3
$15K Hold
76
﹤0.01% 2492
2020
Q2
$21K Hold
76
﹤0.01% 2488
2020
Q1
$21K Hold
76
﹤0.01% 2364
2019
Q4
$28K Buy
+76
New +$21.8K ﹤0.01% 2430
2019
Q2
Sell
-143
Closed -$71K 2803
2019
Q1
$71K Hold
143
﹤0.01% 2173
2018
Q4
$56K Buy
+143
New +$54.1K ﹤0.01% 2332

Other funds holding QTTB

Canada Life's QTTB Position: Q2 2022 in Review

Canada Life sold out of Q32 Bio (QTTB) in Q2 2022, closing a stake of 171 shares — an estimated $9K sold.

Canada Life first reported a position in QTTB in Q4 2018 and held it in 12 quarters. The position peaked at $71K in Q1 2019. 87 funds tracked by Wall St. Rank hold QTTB as of Q2 2022.

  • Canada Life reported no remaining Q32 Bio position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 171 Q32 Bio shares in Q2 2022, an estimated $9K.
  • Canada Life first reported a position in Q32 Bio in Q4 2018 and held it in 12 quarters.
  • Canada Life's Q32 Bio position peaked at $71K in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.